A Democratic congressman is pressing the Department of Justice for answers to a question that’s been on the minds of many Americans since President Donald Trump ordered the quick completion of the marijuana rescheduling process late last year: What’s the hold up?
In a letter sent to Attorney General Pam Bondi and Drug Enforcement Administration (DEA) Administrator Terry Cole on Friday, Rep. Steve Cohen (D-TN) asked for a status update on the pending proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). And he’s also asking the officials to account for why DOJ missed a deadline to issue guidelines easing research barriers into Schedule I drugs—which currently includes cannabis, as well as various psychedelics.
“It is critical that our drug laws and policies enable research and provide patients with access to effective therapies,” Cohen said in the letter, which was exclusively shared with Marijuana Moment ahead of its release.
Trump’s December executive order on cannabis specifically instructed Bondi to finalize the Schedule III rule in “the most expeditious manner.” He didn’t set a deadline for the action, but the Biden administration had already laid the groundwork for a reclassification.
There was a months-long
Read full article on Marijuana Moment
